Discovery of SU086 as an inhibitor of glycolysis and a potential treatment strategy for advanced prostate cancer
The Stoyanova Lab discovers that SU086, an HSP90 inhibitor, inhibits glycolysis and exhibits therapeutic potential ... Read More
February 15, 2022